Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

166
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
166
Genetic Lingo01:11

Genetic Lingo

119.0K
Overview
119.0K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

132
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

20.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.3K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119
Pleiotropy01:33

Pleiotropy

44.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent RNU4-2 n.64_65insT variant in ReNU syndrome identified in exome-negative cases.

Brain & development·2026
Same author

Utility of Urine-Derived Cells for Characterizing Aberrant Splicing Caused by a Novel Deep Intronic L1CAM Variant.

Annals of human genetics·2026
Same author

Functional evidence for SCN8A splice-donor variant c.4419+1 A > G causing loss of function.

Human genome variation·2026
Same author

Hemizygous loss-of-function variants of EIF1AX are associated with a syndromic neurodevelopmental disorder.

European journal of human genetics : EJHG·2026
Same author

Age-dependent electroclinical evolution from focal seizures to epileptic spasms in NUSAP1-related malformations of cortical development.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Genotype-Phenotype Correlations in RPGRIP1-Associated Retinal Dystrophy in a Nationwide Japanese Cohort.

American journal of ophthalmology·2026

Related Experiment Video

Updated: Apr 18, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.1K

SPTAN1 encephalopathy: distinct phenotypes and genotypes.

Jun Tohyama1, Mitsuko Nakashima2, Shin Nabatame3

  • 11] Department of Child Neurology, Nishi-Niigata Chuo National Hospital, Niigata, Japan [2] Niigata University Medical and Dental Hospital, Niigata, Japan.

Journal of Human Genetics
|January 30, 2015
PubMed
Summary

SPTAN1 encephalopathy is a distinct genetic disorder characterized by severe epilepsy and neurological deficits. Specific SPTAN1 gene mutations cause this condition, aiding in diagnosis and understanding of early-onset epileptic encephalopathies.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.6K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.9K

Related Experiment Videos

Last Updated: Apr 18, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.1K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.6K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.9K

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Epileptic encephalopathies are increasingly linked to single-gene disorders.
  • SPTAN1 gene mutations are identified as a cause of early-onset epileptic encephalopathies.

Purpose of the Study:

  • To define SPTAN1 encephalopathy as a distinct clinical syndrome.
  • To identify clinical and neuroimaging hallmarks of SPTAN1 encephalopathy.

Main Methods:

  • Literature review of identified SPTAN1 mutation cases.
  • Clinical and neuroimaging data analysis of affected patients.

Main Results:

  • Seven patients with four distinct in-frame SPTAN1 mutations were identified.
  • Key features include epileptic encephalopathy, hypsarrhythmia, severe intellectual disability, spastic quadriplegia, and specific MRI findings (brainstem/cerebellar atrophy, hypomyelination).
  • A milder variant presents with generalized epilepsy and pontocerebellar atrophy.

Conclusions:

  • In-frame SPTAN1 mutations in the C-terminal region cause dominant negative effects leading to distinct phenotypes.
  • SPTAN1 encephalopathy is a recognizable syndrome crucial for pediatric neurologists to diagnose.
  • Understanding these mutations aids in diagnosing early-onset epileptic encephalopathies.